Publications

Export 23 results:
Author Title [ Type(Desc)] Year
Filters: Keyword is Biomarkers  [Clear All Filters]
Journal Article
Dubois B, Feldman HH, Jacova C, Hampel H, Molinuevo JLuis, Blennow K, DeKosky ST, Gauthier S, Selkoe D, Bateman R et al..  2014.  Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria.. Lancet Neurol. 13(6):614-29.
King NMA, Chambers J, O'Donnell K, Jayaweera SR, Williamson C, Glover VA.  2010.  Anxiety, depression and saliva cortisol in women with a medical disorder during pregnancy.. Arch Womens Ment Health. 13(4):339-45.
Lelental N, Brandner S, Kofanova O, Blennow K, Zetterberg H, Andreasson U, Engelborghs S, Mroczko B, Gabryelewicz T, Teunissen C et al..  2016.  Comparison of Different Matrices as Potential Quality Control Samples for Neurochemical Dementia Diagnostics.. J Alzheimers Dis. 52(1):51-64.
Godlewska BR, Yip SW, Near J, Goodwin GM, Cowen PJ.  2014.  Cortical glutathione levels in young people with bipolar disorder: a pilot study using magnetic resonance spectroscopy.. Psychopharmacology (Berl). 231(2):327-32.
Au B, Smith KJ, Gariépy G, Schmitz N.  2014.  C-reactive protein, depressive symptoms, and risk of diabetes: results from the English Longitudinal Study of Ageing (ELSA).. J Psychosom Res. 77(3):180-6.
Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, Daskalakis ZJ, Dharsee M, Downar J, Evans KR et al..  2016.  Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort.. BMC Psychiatry. 16:105.
Leduc V, Théroux L, Dea D, Dufour R, Poirier J.  2016.  Effects of rs3846662 Variants on HMGCR mRNA and Protein Levels and on Markers of Alzheimer's Disease Pathology.. J Mol Neurosci. 58(1):109-19.
Ménard C, Quirion R, Vigneault E, Bouchard S, Ferland G, Mestikawy SEl, Gaudreau P.  2015.  Glutamate presynaptic vesicular transporter and postsynaptic receptor levels correlate with spatial memory status in aging rat models.. Neurobiol Aging. 36(3):1471-82.
Wimo A, Ballard C, Brayne C, Gauthier S, Handels R, Jones RW, Jonsson L, Khachaturian AS, Kramberger M.  2014.  Health economic evaluation of treatments for Alzheimer's disease: impact of new diagnostic criteria.. J Intern Med. 275(3):304-16.
Ouimet MClaude, Brown TG, Guo F, Klauer SG, Simons-Morton BG, Fang Y, Lee SE, Gianoulakis C, Dingus TA.  2014.  Higher crash and near-crash rates in teenaged drivers with lower cortisol response: an 18-month longitudinal, naturalistic study.. JAMA Pediatr. 168(6):517-22.
Leuzy A, Zimmer ERigon, Bhat V, Rosa-Neto P, Gauthier S.  2014.  Imaging biomarkers for amyloid: a new generation of probes and what lies ahead.. Int Psychogeriatr. 26(5):703-7.
Amoako-Tuffour Y, Jones ML, Shalabi N, Labbe A, Vengallatore S, Prakash S.  2014.  Ingestible gastrointestinal sampling devices: state-of-the-art and future directions.. Crit Rev Biomed Eng. 42(1):1-15.
Richard-Devantoy S, Berlim M, Jollant F.  2014.  A meta-analysis of neuropsychological markers of vulnerability to suicidal behavior in mood disorders.. Psychol Med. 44(8):1663-73.
Petersen RC, Caracciolo B, Brayne C, Gauthier S, Jelic V, Fratiglioni L.  2014.  Mild cognitive impairment: a concept in evolution.. J Intern Med. 275(3):214-28.
Grothe MJ, Villeneuve S, Dyrba M, Bartrés-Faz D, Wirth M.  2017.  Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load.. Neurology. 88(6):569-576.
Parent MJ, Zimmer ER, Shin M, Kang MSu, Fonov VS, Mathieu A, Aliaga A, Kostikov A, Carmo SDo, Dea D et al..  2017.  Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities.. J Neurosci. 37(50):12263-12271.
Heneka MT, Carson MJ, Khoury JEl, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM et al..  2015.  Neuroinflammation in Alzheimer's disease.. Lancet Neurol. 14(4):388-405.
Ng KPin, Pascoal TA, Mathotaarachchi S, Chung C-O, Benedet AL, Shin M, Kang MSu, Li X, Ba M, Kandiah N et al..  2017.  Neuropsychiatric symptoms predict hypometabolism in preclinical Alzheimer disease.. Neurology. 88(19):1814-1821.
Mamdani F, Berlim M, Beaulieu M-M, Turecki G.  2014.  Pharmacogenomic predictors of citalopram treatment outcome in major depressive disorder.. World J Biol Psychiatry. 15(2):135-44.
Eskildsen SF, Coupé P, Fonov VS, Pruessner JC, D Collins L.  2015.  Structural imaging biomarkers of Alzheimer's disease: predicting disease progression.. Neurobiol Aging. 36 Suppl 1:S23-31.
Chaput J-P, Gray CE, Poitras VJ, Carson V, Gruber R, Olds T, Weiss SK, Gorber SConnor, Kho ME, Sampson M et al..  2016.  Systematic review of the relationships between sleep duration and health indicators in school-aged children and youth.. Appl Physiol Nutr Metab. 41(6 Suppl 3):S266-82.
Leh SE, Kälin AM, Schroeder C, Park MTae M, M Chakravarty M, Freund P, Gietl AF, Riese F, Kollias S, Hock C et al..  2016.  Volumetric and shape analysis of the thalamus and striatum in amnestic mild cognitive impairment.. J Alzheimers Dis. 49(1):237-49.
Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT.  2016.  Why has therapy development for dementia failed in the last two decades? Alzheimers Dement. 12(1):60-4.

McGill Logo

CIUSSS ouest montreal logo

 



  • Douglas Hospital
  • Dobell Pavillion
  • Brain imaging centre